Talbot, A., Bobin, A., Tabone, L., Lambert, J., Boccaccio, C., Deal, C., . . . Myélome, I. I. F. d. (2023). Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: The IFM 2020-04 study. Haematologica, 108(10), . https://doi.org/10.3324/haematol.2022.281772

Talbot, Alexis, et al. "Real-world Study of the Efficacy and Safety of Belantamab Mafodotin (GSK2857916) in Relapsed or Refractory Multiple Myeloma Based on Data from the Nominative ATU in France: The IFM 2020-04 Study." Haematologica 108, no. 10 (2023). https://doi.org/10.3324/haematol.2022.281772.

Talbot, Alexis, et al. "Real-world Study of the Efficacy and Safety of Belantamab Mafodotin (GSK2857916) in Relapsed or Refractory Multiple Myeloma Based on Data from the Nominative ATU in France: The IFM 2020-04 Study." Haematologica, vol. 108, no. 10, 2023, https://doi.org/10.3324/haematol.2022.281772.